Frequent mutation of the PIK3CA gene in ovarian and breast cancers

Clinical Cancer Research

Volumn 11, Issue 8, 2005, Pages 2875-2878

  Levine, Douglas A ^a   Bogomolniy, Faina ^a   Yee, Cindy J ^a   Lash, Alex ^a   Barakat, Richard R ^a   Borgen, Patrick I ^a   Boyd, Jeff ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; EXON; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; OVARY CARCINOMA; PIK3CA GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CATALYTIC DOMAIN; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; HUMANS; MODELS, MOLECULAR; MUTATION; MUTATION, MISSENSE; OVARIAN NEOPLASMS; PROTEIN STRUCTURE, TERTIARY;

EID: 17144382038     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2142     Document Type: Article

References (12)

1. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
2. Sun M, Wang G, Paciga JE, et al. AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 2001;159:431-7.
3. Bellacosa A, de Feo D, Godwin AK, et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 1995;64:280-5.
4. Shayesteh L, Lu Y, Kuo W-L, et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999; 21:99-102.
5. Philp AJ, Campbell IG, Leet C, et al. The phosphatidylinositol 3′-kinase p85α gene is an oncogene in human ovarian and colon tumors. Cancer Res 2001;61: 7426-9.
6. Saito M, Okamoto A, KohnoT, et al. Allelic imbalance and mutations of the PTEN gene in ovarian cancer. lnt J Cancer 2000;85:160-5.
7. Sun M, Paciga JE, Feldman RI, et al. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K. Cancer Res 2001;61:5985-91.
8. Samuels Y, Wang Z, Bardelli A, et al. High frequency mutations of the PIK3CA gene in human cancers. Science 2004;304:554.
9. Campbell IG, Russell SE, Choong DY, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 2004;64:7678-81.
10. Walker EH, Perisic O, Ried C, Stephens L, Williams RL. Structural insights into phosphoinositide 3-kinase catalysis and signaling. Nature 1999;402:313-20.
11. Groves MR, Hanlon N, Turowski P, Hemmings BA, Barford D. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 1999;96:99-110.
12. Pirola L, Zvelebil MJ, Bulgarelli-Leva G, Van Obberghen E, Waterfield MD, Wymann MP. Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase α (PIK3α). Functions of lipid kinase-deficient PI3Kα in signaling. J Biol Chem 2001;276:21544-54.